Lanton Law Interviewed by Pharmacy Times Over Prescription Drug Price Executive Order

healthcarepharmaceuticalspharmacy benefit managerprescription drug costsPhRMA

May 14

Lanton Law was quoted in Pharmacy Times’ article titled “President Trump Signs Executive Order Aiming to Lower Prescription Drug Costs by Up to 90%.” The article can be accessed here.

prescription drug pricesExecutive OrderDelivering Most-Favored-Nation Prescription Drug Pricing to American PatientsMost-Favored-Nation (MFN) PricingMFNhealthcareprescriptionpharmaceuticaldrug manufacturer

Ron Lanton

Lanton Law Interviewed by Pharmacy Times Over Prescription Drug Price Executive Order

Bipartisan Bill Aimed At Expanding CMS Coverage Of Rx Digital Therapeutics Re-Introduced

Understanding the 2025 Executive Order on Most-Favored-Nation Drug Pricing: Implications for Healthcare Stakeholders